NCT02780869: A trial that was reported late by Biom'Up France SAS
This trial has reported, although it was 249 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02780869 |
|---|---|
| Title | Prospective, Randomized, Controlled, Multicenter, Pivotal, Clinical Investigation Evaluating the Safety and Efficacy of HEMOBLAST Bellows in Cardiothoracic, Abdominal, and Orthopedic Lower Extremity Surgeries |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | July 18, 2016 |
| Completion date | Feb. 1, 2017 |
| Required reporting date | Feb. 1, 2018, midnight |
| Actual reporting date | Oct. 8, 2018 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 249 |